The Dr. Holhoș network has inaugurated the largest private ophthalmology hospital in Transylvania, following an investment of approximately €6 million.
Romanian patients wait, on average, 460 days to access innovative medicines, even after these therapies have been approved for reimbursement by the National Agency for Medicines and Medical Devices (ANMDM).
7X Partners, a private equity investment company, has acquired a 40% stake in Leventer Medical Group, a centre for dermato-oncology based in Bucharest.
The agreement signifies a joint commitment to enhance healthcare infrastructure in Romania.
ING Bank Romania has financed Medisprof Group, which owns the largest private oncology hospital in western Romania, to expand in the region of Moldova.
OMV Petrom has released its trading update for Q4 2025, revealing a period defined by improved refining performance and strategic adjustments following the extension of production licenses.
Romania's Ministry of Finance will conduct its first public offering of Fidelis government bonds for 2026 between January 16 and 23 on the Bucharest Stock Exchange. This marks the 32nd offering since the Fidelis program resumed in July 2020.
The World Bank revised down Romania's 2026 growth forecast to 1.3%, compared to the 1.9% predicted in June 2025 and 2.6% estimated in January 2025.
Romania's industrial production fell 1.1% as a gross series and 0.5% as a seasonally adjusted series in the first 11 months of the year compared to the same period in 2024, according to the National Institute of Statistics (INS).
Romania's Finance Minister Alexandru Nazare has signed a second €500 million financing contract with the European Investment Bank (EIB) for the Sibiu-Pitești highway project.